NDC Pharmacologic Class N0000175622 Interleukin-2 Receptor Blocking Antibody [EPC]

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
0078-0331Simulect BasiliximabInjection, Powder, For SolutionIntravenousNovartis Pharmaceuticals CorporationHuman Prescription Drug
0078-0393Simulect BasiliximabInjection, Powder, For SolutionIntravenousNovartis Pharmaceuticals CorporationHuman Prescription Drug

There are 2 NDC products with the pharmacologic class Interleukin-2 Receptor Blocking Antibody [EPC].